Zynerba is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

Pharmaceutical

Zynerba Pharma

Stephen O’Quinn

Ray Mannion

Brian Rosenberger

Terri B. Sebree

Terry Hurst

Carol O’Neill

Nancy Tich

Paul M. Kirsch

Samantha Labarbera

Directors and VPs

Leadership Team

Scientific Advisory Team

Teams at Zynerba Pharma

Directors and VPs

Leadership Team

Scientific Advisory Team